Petersen Neuroendocrine Tumor Research Symposium (Watch the presentation beginning at 19:20 minutes into the session recording.) It doesnt provide final answers, but it offers important early clues about how GLP-1 drugs might interact with different types of NENs
SLU-PP-332 is a small molecule, not a peptide, so it behaves somewhat differently in solution than a typical lyophilized peptide
The protein and fiber can help reduce side effects and maximize the benefits you get
Because it targets both GIP and GLP-1 receptors, I felt full faster and stayed full longer
The transformative potential is evident in specific contexts: for patients with high cardiovascular risk, substantial obesity, and access to comprehensive care, including nutritional support, GLP-1 agonists offer unprecedented therapeutic benefits
That said, fiber-rich foods (legumes, oats, onions, Jerusalem artichoke), higher-protein meals, and fermented foods can each modestly support your body's own GLP-1 and satiety signaling through the microbiome and L-cell pathways described above
